Cargando…
Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
BACKGROUND: Fractional exhaled nitric oxide (FENO) is a useful and noninvasive biomarker for eosinophilic airway inflammation, particularly in asthma. However, its utility in chronic obstructive pulmonary disease (COPD) remains controversial. In this study, we performed a systematic review and meta-...
Autores principales: | Lu, Zhiyu, Huang, Weina, Wang, Linfeng, Xu, Ning, Ding, Qunli, Cao, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124452/ https://www.ncbi.nlm.nih.gov/pubmed/30214187 http://dx.doi.org/10.2147/COPD.S165780 |
Ejemplares similares
-
Exhaled nitric oxide in stable chronic obstructive pulmonary disease
por: Beg, Mohammed F. S., et al.
Publicado: (2009) -
Clinical Features of Chronic Obstructive Pulmonary Disease with High Fractional Exhaled Nitric Oxide
por: Ahn, Seong, et al.
Publicado: (2020) -
Treatment of chronic obstructive pulmonary disease in patients with different fractional exhaled nitric oxide levels
por: Wu, Yao-Kuang, et al.
Publicado: (2018) -
Effect of Inhaled β(2)-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease
por: Amer, Mostafa, et al.
Publicado: (2016) -
Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome
por: Guo, Yuanyuan, et al.
Publicado: (2018)